CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guangdong Winsun Bio Pharmaceutical Co L is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guangdong Winsun Bio Pharmaceutical Co L
No. 35 Tianyuan West Road
Huangpu District
Phone: +86 2032221615p:+86 2032221615 GUANGZHOU, GNG  511356  China Ticker: 920729920729
Business Summary
Guangdong Winsun Bio Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production, sales, and technical services of veterinary biological products. The Company's products cover swine vaccines, poultry vaccines and other various types, including monovalent vaccines, multivalent vaccines, and combination vaccines. The Company’s main products include live swine fever vaccine (passaged cell source), trivalent live vaccine for swine fever, swine erysipelas, and swine pasteurellosis and other products. The Company conducts its business in the domestic and overseas markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025-----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
6159 Miscellaneous business credit institutions

Business Names
Business Name
839729
920729

General Information
Number of Employees: 310 (As of 12/31/2025)
Outstanding Shares: 273,350,000 (As of 3/31/2026)
Shareholders: 4,507
Stock Exchange: BJS
Fax Number: +86 2032222399


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, June 3, 2026